title: The backlash against bioequivalence and the interchangeability of brand-name and generic drugs.
authors: Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass., USA. akesselheim@partners.org
authors: Aaron S
authors: AS
authors: Kesselheim
mesh_terms: D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D016568:Drugs, Generic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008297:Male; D013959:Thyroid Diseases / Q000139:chemically induced*
chemical_list: D000889:Anti-Arrhythmia Agents; D016568:Drugs, Generic; D000638:Amiodarone